Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Delivra Health BrandsDHBUF +26.36% Net-Net Working Capital is $0.02 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 406 Drug Manufacturers companies, Delivra Health Brands ranks better than 79.8% on this metric.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
Delivra Health Brands's Net-Net Working Capital for the quarter that ended in Mar. 2026 was $0.02.
The industry rank for Delivra Health Brands's Net-Net Working Capital or its related term are showing as below:
DHBUF's Price-to-Net-Net-Working-Capital is ranked better than 79.8% of 406
companies
in the Drug Manufacturers industry
Industry Median: 8.195
vs DHBUF: 2.80
Delivra Health Brands (OTCPK:DHBUF) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
Delivra Health Brands Net-Net Working Capital Related Terms
Delivra Health Brands Net-Net Working Capital Historical Data
* Premium members only.
The historical data trend for Delivra Health Brands's Net-Net Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delivra Health Brands Net-Net Working Capital Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delivra Health Brands Price-to-Net-Net-Working-Capital vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where Delivra Health Brands's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of $0.02 mean?
Delivra Health Brands (DHBUF) has a Net-Net Working Capital of $0.02 as of Mar. 2026. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Delivra Health Brands According to the industry distribution chart, Delivra Health Brands ranks #82 out of 406 companies in the Drug Manufacturers industry, placing it in the top 20.2%.
Is Delivra Health Brands' Net-Net Working Capital too high?
Delivra Health Brands' current Net-Net Working Capital is $0.02. The Drug Manufacturers industry median Net-Net Working Capital is 8.20. Delivra Health Brands' value of $0.02 is 99.8% below this industry median. Based on the distribution chart, Delivra Health Brands ranks #82 out of 406 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Delivra Health Brands' Net-Net Working Capital compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #82 out of 406 companies for Net-Net Working Capital. This places Delivra Health Brands in the top 20% of its industry — outperforming the majority of peers. The industry median Net-Net Working Capital is 8.20. Delivra Health Brands' value of $0.02 is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Drug Manufacturers company?
The median Net-Net Working Capital among Drug Manufacturers companies is 8.20, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delivra Health Brands's current Net-Net Working Capital of $0.02 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Delivra Health Brands For the Drug Manufacturers industry, the median Net-Net Working Capital is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current Net-Net Working Capital is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.15, compared to a current price of $0.08 — trading 44.1% below its estimated fair value. The current Net-Net Working Capital is $0.02 and 99.8% below the Drug Manufacturers industry median of 8.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current Net-Net Working Capital is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHBUF has been successfully added to your 
